Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The new wound dressing promotes cell growth and healing, absorbs wound fluids well, and is biocompatible.

Vitamin C deficiency changes gene expression, affecting skin and hair health.

Low-frequency electromagnetic fields may help hair growth by affecting certain growth-related molecules.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Tea seed oil in nanostructured carriers stimulates hair growth and feels less greasy when applied.

Interleukin-15 can help hair growth and protect hair follicles.

The hydrogel made of chitosan, HPMC, and insulin speeds up wound healing and could be a new dressing, especially for diabetics.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.